The differential levels of inflammatory cytokines and bdnf among bipolar spectrum disorders

International Journal of Neuropsychopharmacology

Volumn 19, Issue 8, 2016, Pages 1-8

  Wang, Tzu Yun ^a   Lee, Sheng Yu ^a,d   Chen, Shiou Lan ^a,e   Chung, Yi Lun ^a,b   Li, Chia Ling ^a   Chang, Yun Hsuan ^a,c,k   Wang, Liang Jen ^h   Chen, Po See ^a,b   Chen, Shih Heng ^j   Chu, Chun Hsien ^c   Huang, San Yuan ^a,b,g   Tzeng, Nian Sheng ^f   Hsieh, Tsai Hsin ^a   Chiu, Yen Chu ^l   Lee, I Hui ^a,b   Chen, Kao Chin ^a,b   Yang, Yen Kuang ^a,b   Hong, Jau Shyong ^j   Lu, Ru Band ^a,b,c,i  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^h CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

ⁱ NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^j NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^k ASIA UNIVERSITY   (Taiwan)

^l KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

BDNF; Bipolar I disorder; Bipolar II disorder; Bipolar spectrum disorder; Cytokines; Subthreshold bipolarity

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; IL8 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; COMORBIDITY ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; BLOOD; CASE CONTROL STUDY; METABOLISM; YOUNG ADULT;

ADULT; BIOMARKERS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-8; MALE; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84989180859     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyw012     Document Type: Article

References (63)

1. Akiskal HS, Benazzi F (2003) Family history validation of the bipolar nature of depressive mixed states. J Affect Disord 73:113-122.
2. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59 Suppl 1:S5-S30.
3. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK (1977) Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 134:1227-1233.
4. Akiskal HS, Rosenthal RH, Rosenthal TL, Kashgarian M, Khani MK, Puzantian VR (1979) Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry 36:635-643.
5. Angst J (1998) The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50:143-151.
6. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73:133-146.
7. Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler RC, Merikangas KR (2010) Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 167:1194-1201.
8. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68:791-798.
9. Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH (2012) Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 262:3-11.
10. Axelson DA, Birmaher B, Strober MA, Goldstein BI, Ha W, Gill MK, Goldstein TR, Yen S, Hower H, Hunt JI, Liao F, Iyengar S, Dickstein D, Kim E, Ryan ND, Frankel E, Keller MB (2011) Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry 50:1001-1016 e1003.
11. Bai YM, Su TP, Tsai SJ, Wen-Fei C, Li CT, Pei-Chi T, Mu-Hong C (2014) Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J Affect Disord 166:187-192.
12. Bai YM, Su TP, Li CT, Tsai SJ, Chen MH, Tu PC, Chiou WF (2015) Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord 17:269-277.
13. Benazzi F (2001) Is 4 days the minimum duration of hypomania in bipolar II disorder? Eur Arch Psychiatry Clin Neurosci 251:32-34.
14. Benazzi F, Akiskal H (2006) The duration of hypomania in bipolar-II disorder in private practice: methodology and validation. J Affect Disord 96:189-196.
15. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35:804-817.
16. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G (1992) Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 26:127-140.
17. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, Ghenev PI, Aloe L (2004) Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 146:279-289.
18. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL (1993) The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720-727.
19. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS (1995) Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 152:385-390.
20. D'Addario C, et al. (2012) Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 37:1647-1655.
21. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R (2007) Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:952-955.
22. Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
23. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191.
24. Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149-1160.
25. Fernandes BS, Gama CS, Kauer-Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F (2009) Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res 43:1200-1204.
26. Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and metaregression analysis. J Psychiatr Res 45:995-1004.
27. Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH (2011) Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 168:40-48.
28. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 70:1078-1090.
29. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
30. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
31. Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137-162.
32. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, Yin SJ, Lu RB (2004) Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28:374-384.
33. Kapczinski F, Frey BN, Kauer-Sant'Anna M, Grassi-Oliveira R (2008a) Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 8:1101-1113.
34. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM (2008b) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675-692.
35. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with earlyvs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12:447-458.
36. Kim HW, Rapoport SI, Rao JS (2010) Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 37:596-603.
37. Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, Steinbusch HW (2004) T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Res 129:267-272.
38. Letterio JJ, Roberts AB (1997) TGF-beta: a critical modulator of immune cell function. Clin Immunol Immunopathol 84:244-250.
39. Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y (2015) IL-23 and TGF-beta1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord 174:361-366.
40. Li Z, et al. (2014) Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study. Br J Psychiatry 205:29-35.
41. Lin K, Xu G, Lu W, Ouyang H, Dang Y, Guo Y, So KF, Lee TM (2015) Neuropsychological performance of patients with soft bipolar spectrum disorders. Bipolar Disord 17:194-204.
42. Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M (2011) Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 35:769-783.
43. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64:543-552.
44. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741.
45. Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74:15-25.
46. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765.
47. Munkholm K, Brauner JV, Kessing LV, Vinberg M (2013a) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47:1119-1133.
48. Munkholm K, Vinberg M, Vedel Kessing L (2013b) Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord 144:16-27.
49. Nusslock R, Frank E (2011) Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord 13:587-603.
50. O'Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90:263-267.
51. Ortiz-Dominguez A, Hernandez ME, Berlanga C, Gutierrez-Mora D, Moreno J, Heinze G, Pavon L (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9:596-602.
52. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553-1561.
53. Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano GB, Wittchen HU (2005) Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 15:425-434.
54. Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML (2015) BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative metaanalysis. J Affect Disord 174:432-440.
55. Roda A, Chendo I, Kunz M (2015) Biomarkers and staging of bipolar disorder: a systematic review. Trends Psychiatry Psychother 37:3-11.
56. Smith DJ, Forty L, Russell E, Caesar S, Walters J, Cooper C, Jones I, Jones L, Craddock N (2009) Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome. Acta Psychiatr Scand 119:325-329.
57. Spitzer RL, Endicott J, Williams JB (1979) Research diagnostic criteria. Arch Gen Psychiatry 36:1381-1383.
58. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61-64.
59. Tsuang MT, Woolson RF (1977) Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. Br J Psychiatry 130:162-166.
60. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293-299.
61. Wicki W, Angst J (1991) The Zurich Study. X. Hypomania in a 28- to 30-year-old cohort. Eur Arch Psychiatry Clin Neurosci 240:339-348.
62. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435.
63. Zimmerman M (2012) Would broadening the diagnostic criteria for bipolar disorder do more harm than good? Implications from longitudinal studies of subthreshold conditions. J Clin Psychiatry 73:437-443.